Cargando…
Plasma neurofilament light in Huntington’s disease: A marker for disease onset, but not symptom progression
OBJECTIVE: To investigate whether plasma NfL levels correlate with clinical symptom severity in premanifest (PM) and manifest HD (HD) individuals, and whether a NfL cut-point could distinguish PM from HD patients with reasonable accuracy. METHOD: 98 participants (33 control, 26 PM, 39 HD), underwent...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083556/ https://www.ncbi.nlm.nih.gov/pubmed/33940564 http://dx.doi.org/10.1016/j.parkreldis.2021.04.017 |